MR. DONALD A NADEAU DO
Prescription History 1902812480
General Practice in Cranston, RI

NPI Status: Active since August 01, 2006

Contact Information

1312 OAKLAW AVE
MIDLAND MEDICAL
CRANSTON, RI
ZIP 02920
Phone: (401) 463-3380
Fax: (401) 463-3308

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MR. DONALD A NADEAU DO, an active General Practice specialist practicing in Cranston, RI. Our medical registry currently tracks 11 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 411 documented patient claims. Among these therapy options, the most frequently utilized medication is Azithromycin, which accounts for 71 claims alone.


Albuterol Sulfate Hfa

Generic Formulation: Albuterol SulfateSpecialty: General Practice
Provider Metrics Summary
Total Claims 20
30-Day Fills 20.0
Days Supply 427
RI State Average Benchmarks
Peer Average Claims58.0
Peer Average 30-Day Fills66.1
Peer Average Days Supply1,660
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 65.5% less volume than the regional standard for practitioners inside RI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $610.21 across this reporting matrix range.

Provider Avg Cost Per Claim

$30.51

State Avg Cost Per Claim

$45.28

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.

Therapeutic Applications

Albuterol (also known as salbutamol) is used to treat wheezing and shortness of breath caused by breathing problems such as asthma. It is a quick-relief medication. Albuterol belongs to a class of drugs known as bronchodilators. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school.

Amoxicillin-Clavulanate Potass

Generic Formulation: Amoxicillin/Potassium ClavSpecialty: General Practice
Provider Metrics Summary
Total Claims 58
30-Day Fills 58.0
Days Supply 614
RI State Average Benchmarks
Peer Average Claims23.0
Peer Average 30-Day Fills23.4
Peer Average Days Supply193
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 152.2% higher than the standard regional baseline profile for RI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $598.50 across this reporting matrix range.

Provider Avg Cost Per Claim

$10.32

State Avg Cost Per Claim

$12.40

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A fixed-ratio combination of amoxicillin trihydrate and potassium clavulanate.

Therapeutic Applications

Amoxicillin/clavulanic acid is a combination penicillin-type antibiotic used to treat a wide variety of bacterial infections. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

Azithromycin

Generic Formulation: AzithromycinSpecialty: General Practice
Provider Metrics Summary
Total Claims 71
30-Day Fills 71.0
Days Supply 450
RI State Average Benchmarks
Peer Average Claims36.0
Peer Average 30-Day Fills37.7
Peer Average Days Supply309
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 97.2% higher than the standard regional baseline profile for RI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $557.69 across this reporting matrix range.

Provider Avg Cost Per Claim

$7.85

State Avg Cost Per Claim

$9.09

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis.

Therapeutic Applications

This medication is used to treat certain eye infections. It is a macrolide antibiotic that works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness.

Cefuroxime

Generic Formulation: Cefuroxime AxetilSpecialty: General Practice
Provider Metrics Summary
Total Claims 57
30-Day Fills 57.0
Days Supply 847
RI State Average Benchmarks
Peer Average Claims26.0
Peer Average 30-Day Fills26.9
Peer Average Days Supply241
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 119.2% higher than the standard regional baseline profile for RI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,053.94 across this reporting matrix range.

Provider Avg Cost Per Claim

$18.49

State Avg Cost Per Claim

$22.19

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cephalosporin antibiotic.

Therapeutic Applications

Cefuroxime is used to treat a wide variety of bacterial infections. This medication is known as a cephalosporin antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

Ciprofloxacin Hcl

Generic Formulation: Ciprofloxacin HclSpecialty: General Practice
Provider Metrics Summary
Total Claims 33
30-Day Fills 33.0
Days Supply 294
RI State Average Benchmarks
Peer Average Claims24.0
Peer Average 30-Day Fills25.1
Peer Average Days Supply180
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 37.5% more claims than the standard regional baseline profile for RI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $267.39 across this reporting matrix range.

Provider Avg Cost Per Claim

$8.10

State Avg Cost Per Claim

$7.27

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A broad-spectrum antimicrobial carboxyfluoroquinoline.

Therapeutic Applications

This medication is used to treat eye infections. Ciprofloxacin belongs to a class of drugs called quinolone antibiotics. It works by stopping the growth of bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness.

Clotrimazole-Betamethasone

Generic Formulation: Clotrimazole/Betamethasone DipSpecialty: General Practice
Provider Metrics Summary
Total Claims 24
30-Day Fills 24.0
Days Supply 513
RI State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills24.0
Peer Average Days Supply517
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across RI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $570.50 across this reporting matrix range.

Provider Avg Cost Per Claim

$23.77

State Avg Cost Per Claim

$25.33

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This combination medication is used to treat a variety of inflamed fungal skin infections such as ringworm, athlete's foot, and jock itch. This product contains 2 medications. Clotrimazole is an azole antifungal that works by preventing the growth of fungus. Betamethasone is a strong corticosteroid that works by reducing the swelling, redness, and itching that occurs in the skin infection. This medication is not recommended for children younger than 17 years or for diaper rash.

Fluconazole

Generic Formulation: FluconazoleSpecialty: General Practice
Provider Metrics Summary
Total Claims 26
30-Day Fills 26.0
Days Supply 134
RI State Average Benchmarks
Peer Average Claims18.0
Peer Average 30-Day Fills20.0
Peer Average Days Supply201
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 44.4% more claims than the standard regional baseline profile for RI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $437.50 across this reporting matrix range.

Provider Avg Cost Per Claim

$16.83

State Avg Cost Per Claim

$11.00

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.

Therapeutic Applications

Fluconazole is used to treat vaginal yeast infections. It works by stopping the growth of common types of vaginal yeast (fungus). This medication belongs to a class of drugs called azole antifungals.

Furosemide

Generic Formulation: FurosemideSpecialty: General Practice
Provider Metrics Summary
Total Claims 11
30-Day Fills 11.0
Days Supply 298
RI State Average Benchmarks
Peer Average Claims87.0
Peer Average 30-Day Fills161.1
Peer Average Days Supply4,506
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 87.4% less volume than the regional standard for practitioners inside RI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $93.75 across this reporting matrix range.

Provider Avg Cost Per Claim

$8.52

State Avg Cost Per Claim

$7.20

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.

Therapeutic Applications

Furosemide is used to reduce extra fluid in the body (edema) caused by conditions such as heart failure, liver disease, and kidney disease. This can lessen symptoms such as shortness of breath and swelling in your arms, legs, and abdomen. This drug is also used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Furosemide is a water pill (diuretic) that causes you to make more urine. This helps your body get rid of extra water and salt.

Methylprednisolone

Generic Formulation: MethylprednisoloneSpecialty: General Practice
Provider Metrics Summary
Total Claims 66
30-Day Fills 66.0
Days Supply 420
RI State Average Benchmarks
Peer Average Claims33.0
Peer Average 30-Day Fills34.2
Peer Average Days Supply242
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 100.0% higher than the standard regional baseline profile for RI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $540.19 across this reporting matrix range.

Provider Avg Cost Per Claim

$8.18

State Avg Cost Per Claim

$11.67

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A PREDNISOLONE derivative with similar anti-inflammatory action.

Therapeutic Applications

Methylprednisolone is used to treat conditions such as arthritis, blood disorders, severe allergic reactions, certain cancers, eye conditions, skin/kidney/intestinal/lung diseases, and immune system disorders. It decreases your immune system's response to various diseases to reduce symptoms such as swelling, pain, and allergic-type reactions. This medication is a corticosteroid hormone. Methylprednisolone may also be used with other medications in hormone disorders.

Oseltamivir Phosphate

Generic Formulation: Oseltamivir PhosphateSpecialty: General Practice
Provider Metrics Summary
Total Claims 33
30-Day Fills 33.0
Days Supply 170
RI State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills22.6
Peer Average Days Supply166
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 50.0% more claims than the standard regional baseline profile for RI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,517.74 across this reporting matrix range.

Provider Avg Cost Per Claim

$45.99

State Avg Cost Per Claim

$71.06

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An acetamido cyclohexene that is a structural homolog of SIALIC ACID and inhibits NEURAMINIDASE.

Therapeutic Applications

Oseltamivir is used to treat symptoms caused by the flu virus (influenza). It helps make the symptoms (such as stuffy nose, cough, sore throat, fever/chills, aches, tiredness) less severe and shortens the recovery time by 1-2 days. This medication may also be used to prevent the flu if you have been exposed to someone who already has the flu (such as a sick household member) or if there is a flu outbreak in the community. Talk to your doctor for more details. This medication works by stopping the flu virus from growing. It is not a substitute for the flu vaccine. (See also Notes section.)

Sulfamethoxazole-Trimethoprim

Generic Formulation: Sulfamethoxazole/TrimethoprimSpecialty: General Practice
Provider Metrics Summary
Total Claims 12
30-Day Fills 12.0
Days Supply 122
RI State Average Benchmarks
Peer Average Claims25.0
Peer Average 30-Day Fills27.9
Peer Average Days Supply355
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 52.0% less volume than the regional standard for practitioners inside RI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $67.15 across this reporting matrix range.

Provider Avg Cost Per Claim

$5.60

State Avg Cost Per Claim

$5.29

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A drug combination with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including PNEUMOCYSTIS PNEUMONIA in AIDS.

Therapeutic Applications

This medication is a combination of two antibiotics: sulfamethoxazole and trimethoprim. It is used to treat a wide variety of bacterial infections (such as middle ear, urine, respiratory, and intestinal infections). It is also used to prevent and treat a certain type of pneumonia (pneumocystis-type). This medication should not be used by children less than 2 months of age due to the risk of serious side effects. This medication treats only certain types of infections. It will not work for viral infections (such as flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like MR. DONALD A NADEAU DO provides transparency into local medical care patterns within Cranston, RI.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **General Practice** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.